Article Text

Download PDFPDF
The role of Müller cells in tractional macular disorders: an optical coherence tomography study and physical model of mechanical force transmission
  1. Andrea Govetto1,
  2. Jean-Pierre Hubschman2,
  3. David Sarraf3,4,
  4. Marta S Figueroa5,
  5. Ferdinando Bottoni6,
  6. Roberto dell'Omo7,
  7. Christine A Curcio8,
  8. Patrizio Seidenari1,
  9. Giulia Delledonne6,
  10. Robert Gunzenhauser2,
  11. Mariantonia Ferrara9,
  12. Adrian Au3,
  13. Gianni Virgili10,
  14. Antonio Scialdone1,
  15. Rodolfo Repetto11,
  16. Mario R Romano9
  1. 1 Department of Ophthalmology, Fatebenefratelli-Oftalmico Hospital, ASST-Fatebenefratelli-Sacco, Milan, Italy
  2. 2 Retina Division, Stein Eye Institute, UCLA, Los Angeles, California, USA
  3. 3 Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, UCLA, Los Angeles, California, USA
  4. 4 Department of Ophthalmology, Greater Los Angeles VA Healthcare Center, Los Angeles, California, USA
  5. 5 Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain
  6. 6 Eye Clinic, Department of Biomedical and Clinical Science ‘Luigi Sacco’, Sacco Hospital, University of Milan, Milan, Italy
  7. 7 Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
  8. 8 Department of Ophthalmology, University of Alabama at Birmingham College of Arts and Sciences, Birmingham, Alabama, USA
  9. 9 Eye Unit, Humanitas University, Humanitas-Gavazzeni Hospital, Bergamo, Italy
  10. 10 Department of Ophthalmology, Careggi University Hospital, University of Florence, Florence, Italy
  11. 11 Department of Civil, Chemical and Environmental Engineering, University of Genoa, Genoa, Italy
  1. Correspondence to Dr Andrea Govetto, Ophthalmology Department, Fatebenefratelli-Oftalmico Hospital, ASST-Fatebenefratelli-Sacco, Via Castelfidardo 15, 20121, Milan, Italy; a.govetto{at}gmail.com

Footnotes

  • Funding J-PH: consultant for Alcon (Fort Wort, TX, USA), Allergan (Dublin, Ireland); DS: consultant for Amgen (Thousand Oaks, CA, USA), consultant and speaker for Bayer (Leverkusen, Germany), consultant and researcher for Genentech (San Francisco, CA, USA), researcher for Heidelberg (Heidelberg, Germany), speaker for Novartis (Basel, Switzerland), consultant, researcher and speaker for Optovue (Freemont, CA, USA), researcher for Regeneron (Tarrytown, NY, USA); MSF: consultant for Novartis (Basel, Switzerland), Alcon (Fort Wort, TX, USA), Bayer (Leverkusen, Germany), Allergan (Dublin, Ireland), Hoffman LaRoche (Basel, Switzerland), Zeiss (Oberkochen, Germany); FB: consultant for Novartis (Basel, Switzerland), Bayer (Leverkusen, Germany); CC: Consultant for Genentech (San Francisco, California, USA), Merck (Whitehouse Station, New Jersey, USA) Janssen Cell Therapy (Raritan, New Jersey, USA); research support from Hoffman LaRoche (Basel, Switzerland). MRR: research grants from Alcon (Fort Wort, TX, USA); DORC (Zuidland, Holland); Baush & Lomb (Rochester, NY, USA); Bayer (Leverkusen, Germany), consultant for Leica (Wetzlar, Germany).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon request.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding J-PH: consultant for Alcon (Fort Wort, TX, USA), Allergan (Dublin, Ireland); DS: consultant for Amgen (Thousand Oaks, CA, USA), consultant and speaker for Bayer (Leverkusen, Germany), consultant and researcher for Genentech (San Francisco, CA, USA), researcher for Heidelberg (Heidelberg, Germany), speaker for Novartis (Basel, Switzerland), consultant, researcher and speaker for Optovue (Freemont, CA, USA), researcher for Regeneron (Tarrytown, NY, USA); MSF: consultant for Novartis (Basel, Switzerland), Alcon (Fort Wort, TX, USA), Bayer (Leverkusen, Germany), Allergan (Dublin, Ireland), Hoffman LaRoche (Basel, Switzerland), Zeiss (Oberkochen, Germany); FB: consultant for Novartis (Basel, Switzerland), Bayer (Leverkusen, Germany); CC: Consultant for Genentech (San Francisco, California, USA), Merck (Whitehouse Station, New Jersey, USA) Janssen Cell Therapy (Raritan, New Jersey, USA); research support from Hoffman LaRoche (Basel, Switzerland). MRR: research grants from Alcon (Fort Wort, TX, USA); DORC (Zuidland, Holland); Baush & Lomb (Rochester, NY, USA); Bayer (Leverkusen, Germany), consultant for Leica (Wetzlar, Germany).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.